1988
DOI: 10.1159/000469140
|View full text |Cite
|
Sign up to set email alerts
|

Lysosomal Accumulation of Phospholipids in Mucolipidosis IV Cultured Fibroblasts

Abstract: Pulse-chase studies were performed to investigate the metabolism of phosphatidylethanolamine (PEA) in cultured fibroblasts from patients with mucolipidosis type IV (MLIV) and normal controls. When cultured cells were incubated with ^3 H-ethanolamine, 80-90% of the intracellular radioactivity was associated with PEA. Compared to the metabolism of ^3 H-PEA in normal cells, the phospholipid was retained in greater amounts and degraded more slowly in the MLIV fibroblasts. The ^3 H-PEA concentration in lysosomal pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1989
1989
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…ML is a collective name for the group of autosomal recessive diseases in which the accumulated substrate is phospholipid (Mancini et al, 2000;Mach, 2002). There are four types of ML, types I-III involve the mis-targeting of lysosomal lipid hydrolases, resulting in inefficient processing of endocytosed lipids (Bach and Desnick, 1988;Bargal and Bach, 1989;Slaugenhaupt, 2002). Type IV (ML IV), however, differs slightly as it is linked to mutations in the proposed ionchannel, mucolipin 1 (MCOLN1), a protein suggested to play a role in lysosomal/endosome function (Bargal and Bach, 1989;Fares and Greenwald, 2001;LaPlante et al, 2004).…”
Section: Mucolipidosis (Ml)mentioning
confidence: 99%
“…ML is a collective name for the group of autosomal recessive diseases in which the accumulated substrate is phospholipid (Mancini et al, 2000;Mach, 2002). There are four types of ML, types I-III involve the mis-targeting of lysosomal lipid hydrolases, resulting in inefficient processing of endocytosed lipids (Bach and Desnick, 1988;Bargal and Bach, 1989;Slaugenhaupt, 2002). Type IV (ML IV), however, differs slightly as it is linked to mutations in the proposed ionchannel, mucolipin 1 (MCOLN1), a protein suggested to play a role in lysosomal/endosome function (Bargal and Bach, 1989;Fares and Greenwald, 2001;LaPlante et al, 2004).…”
Section: Mucolipidosis (Ml)mentioning
confidence: 99%
“…There are four types of ML, three of which (MLII, MLIIIa, and MLIIIC) involve incorrect intracellular targeting of lysosomal lipid hydrolases, resulting in inefficient processing of endocytosed lipids (3)(4)(5). Although the cellular phenotype of type IV (MLIV) is similar to other MLs, MLIV is linked to mutations in the ion channel, mucolipin 1 (TRP-ML1), a member of the TRP family of ion channels (6 -8).…”
Section: Mucolipidosis (Ml)mentioning
confidence: 99%
“…Other clinical manifestations of MLIV include achloridia and hypergastrinaemia (Schiffmann et al 1998;Lubensky et al 1999). At the cellular level, MLIV is a classic lysosomal storage disease with accumulation, in virtually all tissues and cells, of electron-dense vesicles and membranous inclusions containing phospholipids (Bach & Desnick, 1988;Bargal & Bach, 1989) and gangliosides (Zeigler & Bach, 1986). Proteolysis defects have not been shown in MLIV.…”
Section: Mucolipin 1 and MLIVmentioning
confidence: 99%